Recent headlines from the sources AlphaScala monitors. AlphaScala analysis is published in the main market section.
Ondas (ONDS) buys 100% of Omnisys, an Israeli developer of AI-powered battle resource software, signaling a push into software-defined defense. Next integration details.
MindWalk's systematic report names over 20 antibody candidates, 10 in partner-funded clinical trials. The three most important signals for traders now.
Starmer's no-timetable stance caps UK political uncertainty. The by-election in Makerfield is the next trigger. For AAPL, the broader market, the crisis looks contained.
An analyst's buy call highlights absolute EBITDA growth offsetting weak margins. Flywire's operating leverage inflection is the key re-rating risk for investors.
Lowe's partners with MrBeast on toys and workshops to capture Gen Alpha. The lipstick effect logic: small purchases during a big-ticket slowdown. A low-cost bet with a clear traffic test ahead.
After a 2024 setback, THG is back to profit. Now Myprotein's seven-store Footasylum trial reveals the offline margin trade-off.
The Fidelis Partnership's Broker Connect uses AI to automate pre-bind submissions, with Howden as first partner. The platform targets fragmented manual processes in complex risk placement.
Morgan Stanley splits chip equipment: upgrades Lam Research, cuts Applied Materials. AMAT score 68, LRCX 73. Pair trade in play. Confirm from orders next.
Digi Power X upgraded after the Cerebras deal. The partnership introduces execution and concentration risks. The upgrade signals a shift in risk/reward for DGXX investors.
Onto Innovation's $1.1B convertible senior notes due 2031 include a $165M option. The offering shifts the risk profile and signals management's view on capital needs.
Meta starts 8,000 job cuts this week as AI capex hits $145B. Employee morale plunges 25% on Blind. Internal tracking tool sparks petition. META stock down 7% YTD. Risk event watch.
A Seeking Alpha analyst disclosed a long BNL position with four unrevealed REITs. Without full data on coverage and leverage, the yield thesis is incomplete. Rate risk is the next test.
Berkshire's Q1 2026 13F portfolio trimming poses risk of overextrapolation as a macro signal. Watchlist: monitor for next filing or Buffett commentary. BRK.B Alpha Score 55.
Alinma Retail REIT fundunits hit a 52-week high on May 18. The move signals renewed interest in Saudi retail REITs. A break above resistance could confirm sector rotation.
Grant revenue dropped to $0 and net loss hit $8.0M after RewinD-LB completion. CervoMed now faces a binary path: new trial or capital raise.
LIRR strike enters first full workday, testing NYC commuter resilience. A prolonged disruption could accelerate remote work trends and pressure office REITs. Settlement before Wednesday limits damage.
Benioff's admission that Salesforce uses AI to scan Slack messages creates a governance and employee trust risk that CRM investors should not ignore.
KinderCare Q1 2026 results confirm weak enrollment and occupancy, reinforcing a hold rating. No recovery timeline offered. Next quarter's occupancy data is the trigger.
TOYO's Q1 revenue missed by $60.1M, overshadowing a $0.03 EPS beat. The gap raises questions about growth trajectory and valuation support.
A five-stock cluster hit 52-week lows on TASI May 18. Sector grouping and volume will determine whether this is a sector rotation signal or a broad risk-off warning for traders.
Six Saudi stocks fell to their lowest since debut on May 18. The breadth event demands follow-through analysis for TASI traders.
Sport Clubs Co. opened a new female branch in Dammam under Body Motions, expanding in Saudi's female fitness market. Further openings are planned, making this a key growth catalyst for investors.
SAL and Naseej Tech adjust on May 18. The ex-dividend gap and ex-bonus repricing create a short-term test. Watch volume and the close for confirmation.
A tech executive's lawsuit win over Tesla's Full Self-Driving claims creates a legal precedent that could pressure TSLA's valuation and force marketing changes.
Berkshire's first filing under Greg Abel shows a $2.6B Delta stake, a 224% Alphabet increase, and exits from Amazon, Mastercard, Visa. Alpha Score 55/100 Moderate.
Vyvanse exclusivity loss pressures Takeda revenue; pipeline must deliver growth fill the gap. Alpha Score 38 signals neutral risk. Key catalysts ahead.
Saudi-listed hospital group CFO Amin Hariz says seasonal compression drove Q1 profit dip. Q2 results on Tadawul will test the demand thesis.
With 700,000 HK medical visits in Shenzhen last year, Bupa's new plan integrates outpatient coverage. Three signals will tell if it scales.
Dar Al Arkan plans USD-denominated, Shariah-compliant sukuk under Reg S. The fixed-rate senior unsecured deal tests credit appetite in a mixed real estate market. Pricing guidance will signal market confidence.
Bloom Energy Q1 revenue surged 130% 130% to $751M, crushing estimates. Analyst Beth Kindig calls it top 2026 pick as AI power demand drives structural re-rating.